Population pharmacokinetics (PK) and pharmacodynamics (PD) of quinapril (Q) in infants, children, and adolescents.

被引：0
|
作者：
Ouellet, D [1 ]
Olson, S [1 ]
Roman, D [1 ]
Keller, LH [1 ]
机构：
[1] Global Res & Dev, Ann Arbor, MI USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2003年 / 73卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(03)90625-4
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P72 / P72
页数：1
相关论文
共 50 条
  • [1] POPULATION PHARMACOKINETICS OF INTRAVENOUS ACETAMINOPHEN IN NEONATES, INFANTS, CHILDREN AND ADOLESCENTS.
    Pan, C. P.
    Marier, J. F.
    Mouksassi, M. S.
    Breitmeyer, J. B.
    Royal, M. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S7 - S7
  • [2] FAMOTIDINE PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) IN CHILDREN
    JAMES, L
    MARSHALL, J
    HEULITT, M
    WELLS, T
    KEARNS, G
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 179 - 179
  • [3] Population pharmacokinetics (PK) pharmacodynamics (PD) of minoxidil (MNX).
    Fadiran, EO
    Miller, R
    Ludden, T
    Karkowsky, A
    Parekh, A
    Ferry, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII46 - PII46
  • [4] PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF ATENOLOL (ATN) IN CHILDREN
    BUCK, M
    WIEST, D
    GILLETTE, P
    TRIPPEL, D
    KRULL, J
    ONEAL, W
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (02) : 138 - 138
  • [5] Pharmacokinetics (PK) and pharmacodynamics (PD) of sotalol in a pediatric population: Results of the first controlled PK/PD study of an antiarrhythmic in children
    Saul, JP
    Schaffer, MS
    Ross, B
    Beerman, L
    Epstein, M
    Erickson, CC
    Karpawich, PP
    Melikian, AP
    Williams, JH
    Shi, J
    Barbey, J
    Hinderling, PH
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 49A - 49A
  • [6] POPULATION (POP) PHARMACOKINETICS (PK) PHARMACODYNAMICS (PD) OF TRIAZOLAM (TZ)
    GUPTA, SK
    HEGE, S
    ELLINWOOD, EH
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 199 - 199
  • [7] Pharmacokinetics (PK) and pharmacodynamics (PD) of nizatidine (NIZ) in young infants.
    Abdel-Rahman, SM
    Johnson, FK
    Staiano, A
    Manowitz, N
    Kearns, GL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P38 - P38
  • [8] Pharmacokinetics (PK) of rifapentine (RIF) in adolescents.
    Marshall, JD
    Kauffman, RE
    Keung, A
    Johnson, KM
    Abdel-Rahman, S
    Kearns, GL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 139 - 139
  • [9] Pharmacokinetics and pharmacodynamics of AQUAVAN® bolus injection: a population PK/PD model®
    Gibiansky, E.
    Struys, M.
    Gibiansky, L.
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2004, 21 : 15 - 15
  • [10] Population pharmacokinetics (PK) and pharmacodynamics (PD) of integrelin, a platelet aggregation inhibitor
    Sambol, NC
    Tcheng, JE
    Kitt, M
    Lorenz, T
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PI84 - PI84
12345